UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

HFSA CardioAbstracts: HELIOS-B

Details

People with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) face high rates of illness and death. In the HELIOS-B trial, vutrisiran reduced the risk of all-cause and cardiovascular mortality, CV hospitalizations, HF hospitalizations, and urgent HF visits compared with placebo. In this session, HFSA faculty will review new findings from the open-label extension study and a post hoc analysis of HELIOS-B.

Please visit our post-module evaluation survey as well! Link to survey: https://www.surveymonkey.com/r/8RL5D9K